OIS@AAO 2014

Translatum Medicus Developing Option To Treat Dry AMD

Translatum Medicus Developing Option To Treat Dry AMD

By Tom Salemi | November 7, 2014

Clinicians have few treatment options for dry AMD, but Translatum Medicus Inc., is working on an agent, TMi-018, for such an indication. President and CSO…

Read More
Panoptes Developing Inhibitor For Local Treatments In Ocular Disease

Panoptes Developing Inhibitor For Local Treatments In Ocular Disease

By Tom Salemi | November 7, 2014

Panoptes Pharma GmhB is developing PP-001, a dihydroorotate dehydrogenase (DHODH) inhibitor for local treatments in ocular disease, Co-Founder and CEO Franz Obermayr, PhD, told the…

Read More
How Alcon and Google Could Change The Contact Lens

How Alcon and Google Could Change The Contact Lens

By Tom Salemi | October 28, 2014

Moderator: Gilbert H. Kliman, MD Dr. Gil Kliman leads the medical device investment team at InterWest Partners and invests in a broad array of healthcare…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.